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Abstract
Introduction—Excessive alcohol use is associated with car crashes, violence, and multiple 
disease conditions, including fetal alcohol spectrum disorders. The U.S. Preventive Services Task 
Force (USPSTF) recommends that primary care providers screen all adults and conduct brief 
counseling interventions with those who misuse alcohol. The USPSTF prefers use of three 
screening tools that measure alcohol consumption (Alcohol Use Disorders Identification Test, 
Alcohol Use Disorders Identification Test-Consumption, and National Institute on Alcohol Abuse 
and Alcoholism Single Question) because these tools detect the full spectrum of alcohol misuse in 
adults. This study estimated the prevalence of primary care provider screening practices for 
alcohol misuse and examined factors associated with using a USPSTF-preferred screening tool.
Methods—In 2016, a cross-sectional analysis was conducted on self-reported 2016 DocStyles 
data to estimate the prevalence of different screening tools used by 1,506 primary care providers—
family practitioners, internists, obstetrician/gynecologists, and nurse practitioners. Adjusted 
prevalence ratios were calculated using logistic regression to examine the association between 
provider attributes and use of USPSTF-preferred screening tools.
Results—In this study, 96% of providers reported screening patients for alcohol misuse. Among 
those that screened, 38% used a USPSTF-preferred screening tool. Provider specialty, awareness 
of USPSTF guidelines, and mode of administering screening tool were associated with using a 
preferred screening tool.
Conclusions—Although most primary care providers reported screening for alcohol misuse, 
about two thirds did not use a tool capable of detecting the full spectrum of alcohol misuse. Using 
suitable screening tools will better identify patients who misuse alcohol and increase the 
opportunity for appropriate intervention, ultimately helping to reduce the burden from the many 
conditions associated with excessive alcohol consumption.
INTRODUCTION
Excessive alcohol consumption is associated with car crashes, violence, and more than 60 
disease conditions,1 including hypertension, sleep disorders, various cancers, liver cirrhosis, 
and alcohol use disorders.2–4 In addition, maternal drinking during pregnancy can result in 
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fetal alcohol spectrum disorders in the baby,5 and is associated with other poor birth 
outcomes, such as miscarriage, stillbirth, preterm birth, and sudden infant death syndrome.6 
Reducing the burden from the health conditions associated with excessive drinking requires 
a focus on prevention—specifically, not only identifying patients with alcohol-related harm 
and alcohol use disorders, but also patients who are drinking in excess.7,8
For the purpose of this study, the term excessive alcohol use includes exceeding single-day 
limits (more than four drinks for men and more than three drinks for women in a single day), 
binge drinking (greater than single-day limits within a 2-hour period), exceeding weekly 
limits (more than 14 drinks for men and more than seven drinks for women per week), and 
any drinking by pregnant women or people under age 21 years.9,10 Estimates from 2009 to 
2011 found that the prevalence of excessive drinking in the U.S. was 29.3% and the 
prevalence of alcohol dependence was 3.5%; these estimates indicate that nondependent 
excessive drinkers outnumber dependent drinkers by more than eight to one.11
In 2004, the U.S. Preventive Services Task Force (USPSTF) found “good evidence that 
screening in primary care settings can accurately identify patients whose levels or patterns of 
alcohol consumption do not meet criteria for alcohol dependence, but place them at risk for 
increased morbidity and mortality” and that brief behavioral counseling interventions help 
reduce their alcohol consumption.12 This recommendation included a list of screening 
instruments for clinical use. Some of these screening tools, including the widely used CAGE 
(acronym for the four questions of the screening tool: Cut down, Annoyed, Guilty, Eye 
opener) questionnaire13–15 —which evaluates alcohol-related harm and alcohol dependence 
symptoms only,8 and not alcohol consumption—may be appropriate for detecting alcohol 
abuse and dependence, but are less capable of identifying non-dependent patients who drink 
too much.13,16 In 2013, the USPSTF updated their recommendation indicating a preference 
for three screening instruments that evaluated alcohol consumption and could, therefore, 
identify the full spectrum of alcohol misuse, defined as excessive alcohol use, alcohol abuse, 
and alcohol dependence.9 The tools had adequate sensitivity and specificity to identify 
which patients should receive a brief intervention.13 The three tools, which can be 
administered in 5 minutes or less, are the ten-question Alcohol Use Disorders Identification 
Test (AUDIT),17 the three-question AUDIT-Consumption (AUDIT-C),18 and single question 
screeners such as the National Institute on Alcohol Abuse and Alcoholism Single Question 
(NIAAA Single Question).19
Surveys among primary care providers (PCPs) and residents find a range of estimates for the 
prevalence of alcohol screening and use of different screening tools. Based on a 2010–2012 
survey, 60% of medical residents from family and internal medicine programs in the 
Southeastern U.S. reported screening new patients for alcohol consumption, and 19% used 
tools that were capable of detecting excessive alcohol consumption.20 Compared with 
residents, providers reported a higher prevalence of screening in nationwide surveys, ranging 
from 85% to 88%,14,21 with a majority not using a formal screening tool.15,21,22 When they 
used a validated instrument, they most commonly used the CAGE questionnaire.14,15 All of 
these studies were based, however, on data collected before the updated 2013 USPSTF 
recommendations. Moreover, because these studies do not estimate the prevalence of using 
specific screening tools, the percentage of providers using a tool capable of identifying the 
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full spectrum of alcohol misuse behaviors cannot be determined. To fill these gaps, this 
study aims to describe current practices reported by PCPs when screening for alcohol misuse 
and to determine what demographics and practice characteristics are associated with using 
USPSTF-preferred screening tools.
METHODS
Study Sample
DocStyles is a survey developed by Porter Novelli with input from federal agencies and 
nonprofit and for-profit clients, which examines the knowledge, attitudes, and behaviors 
reported by healthcare providers in the U.S. Medical professionals registered with SERMO 
(an online global social network consisting of >350,000 medical professionals) were invited 
to be a part of the 2016 DocStyles survey. SERMO membership is free for medical 
professionals. Porter Novelli was responsible for setting sample size quotas in the following 
specialties: internists, family practitioners, obstetrician/gynecologists (OB/GYNs), and nurse 
practitioners. Healthcare professionals were eligible for the survey if they practiced in the 
U.S., actively saw patients, worked in individual/ group/hospital practices, and had been 
practicing for ≥3 years. For the web-based survey, 2,384 respondents were invited to 
participate in June 2016; 1,506 respondents completed the survey (480 family practitioners, 
523 internists, 250 OB/GYNs, and 253 nurse practitioners). Respondents were paid an 
honorarium of $42–$90, depending on the number of questions they were asked. The overall 
response rate was 63.2% and differed by specialty (nurse practitioners 41.3%, OB/GYNs 
71.4%, family practitioners and internists 70.5%). Comparing internists, family 
practitioners, and OB/GYNs in this sample to the American Medical Association Physician 
Masterfile, this sample had a higher percentage of males (sample: 70%, American Medical 
Association: 63%) and had a lower mean for years in practice (sample: 17 years, American 
Medical Association: 22 years).
This research was exempt from IRB approval because the data file provided by Porter 
Novelli did not include personal identifiers.
Measures
DocStyles has a set of standard questions about provider demographics (age, gender, race/
ethnicity) and practice characteristics (specialty, inpatient/outpatient setting, years in 
practice, patients per week, practice size, region, financial situation of patients). These were 
included as potential covariates.
To ascertain screening practices for alcohol misuse, respondents were asked three questions. 
First, providers were asked whether alcohol screening and brief intervention (SBI) is a 
clinical preventive service recommended by the USPSTF. Second, they were asked to select 
all screening tools they used from the following list: AUDIT/AUDIT-C, CAGE, CRAFFT 
(acronym for the six questions of the screening tool: Car, Relax, Alone, Forget, Family or 
friends, Trouble), T-ACE (acronym for the four questions of the screening tool: Tolerance, 
Annoyance, Cut down, Eye opener), TWEAK (acronym for the five questions of the 
screening tool: Tolerance, Worried, Eye opener, Amnesia, Cut down), NIAAA Single 
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Question, ask number of drinks per occasion, ask frequency of drinking, don’t use formal 
screening tool, or don’t screen. The survey question included a definition of the NIAAA 
Single Question, specifically, How many times in the past year have you had 4 (women)/5 
(men) or more drinks in a day? Third, respondents who reported screening using a formal or 
informal tool were asked whether screening questions were administered via in-person 
interview, form, electronically, or using other methods.
A binary dependent variable indicating whether the respondent used a preferred USPSTF 
screening tool was constructed from the question about screening tools. Respondents who 
selected the AUDIT/AUDIT-C or the NIAAA Single Question or both were classified as 
using a USPSTF-preferred screening tool.
Statistical Analysis
Analyses were conducted in 2016 using SAS-callable SUDAAN, version 11.0.1. Descriptive 
statistics of provider demographics and practice characteristics were presented for each 
specialty and for all four specialties combined. Responses to the three questions about 
screening for alcohol misuse were also presented for each specialty and for all four 
specialties combined. Bivariate analyses were conducted to estimate the prevalence of using 
a USPSTF-preferred screening tool by provider demographics, practice characteristics, and 
screening practices. Unadjusted p-values from chi-square tests were used to determine which 
variables had significant (p≤0.05) bivariate associations. Provider demographics commonly 
included in studies using DocStyles data, and covariates with significant associations in 
bivariate analyses, were included in a multivariate logistic regression to obtain adjusted 
prevalence ratios (APRs) and their corresponding 95% CIs. The APRs and their CIs were 
similar for this parsimonious model and a model (not shown) that included all 11 potential 
covariates in Tables 1 and 2, providing evidence for robustness and lack of overfitting. The 
model was assessed for multicollinearity using condition indices and variance 
decomposition factors and no multicollinearity was found.
RESULTS
Within the sample, most PCPs were male (60%), white non-Hispanic (66%), worked in 
group outpatient practices (65%), and saw ≥100 patients per week (56%), but differences 
existed by PCP specialty (Table 1). In particular, 88% of nurse practitioners were female, 
and only 26% saw ≥100 patients per week. A majority of nurse practitioners and internists 
worked in practices with more than five providers, whereas a majority of OB/ GYNs and 
family practitioners worked in practices with five or fewer providers. Age differences also 
existed between specialties.
Most PCPs surveyed (81%) were aware that the USPSTF recommends alcohol screening 
and brief counseling for all adults and most (96%) reported screening adult patients for 
alcohol misuse (Table 2). However, most did not report using a USPSTF-preferred screening 
tool: 56% used the CAGE, 46% asked about drinking frequency, and 42% asked about 
number of drinks per occasion. Compared with other PCP specialties, OB/GYNs reported 
the highest prevalence of using other screening methods (20%), T-ACE (10%), and TWEAK 
(4%). The most common mode of administering screening tools was via in-person interview, 
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with 63% of providers reporting screening via in-person interview only, and another 18% 
reporting screening via in-person interview and form. By contrast, only 11% of providers 
screened via form only.
Among providers in this study who reported screening patients (96%), the prevalence of 
using a USPSTF-preferred screening tool was 38% (Table 3). Bivariate analyses showed that 
the following variables were significantly associated with using a USPSTF-preferred 
screening tool: provider specialty (p<0.001), size of practice (p=0.041), awareness of the 
USPSTF recommendation on alcohol SBI (p=0.003), and mode through which screening 
questions were administered (p<0.001). Controlling for these variables and provider 
demographics in a multivariate model showed that the prevalence of using a USPSTF-
preferred screening tool was significantly lower among OB/GYNs than other specialties. In 
the same multivariate model, use of a USPSTF-preferred screening tool was 22% higher 
among providers aware of the USPSTF recommendation on alcohol SBI (APR=1.22, 95% 
CI=1.02, 1.47), 56% higher among providers who administered screening questions via in-
person interview compared with form only (APR=1.56, 95% CI=1.17, 2.07), and 152% 
higher among providers who administered screening questions via in-person interview and 
form compared with form only (APR=2.52, 95% CI=1.88, 3.37).
DISCUSSION
This study describes current alcohol misuse screening practices reported by a sample of U.S. 
PCPs, and is the first study examining providers’ reported use of USPSTF-preferred 
screening tools. Similar to the prevalence of provider-reported tobacco screening,23,24 
almost all PCPs surveyed reported screening patients for alcohol misuse. However, only two 
in five providers (38%) who screened used a USPSTF-preferred screening tool. This means 
that most PCPs surveyed were willing to ask patients about their alcohol use, but more than 
half may not be using screening tools capable of detecting the full spectrum of alcohol 
misuse, especially patients who drink excessively, but do not meet criteria for alcohol 
dependence. Predictors of using a preferred screening tool include physician specialty, 
awareness of the USPSTF recommendation on alcohol SBI, and mode of administering 
screening questions.
PCPs who do not screen for the full spectrum of alcohol misuse are likely to miss 
identifying many patients who could benefit from a brief intervention. A brief intervention is 
typically a 6-minute to 15-minute interaction between the patient and provider about 
motivation to reduce or stop alcohol consumption and potential steps that would help.9,25 
Research shows that multiple-session brief interventions are effective at reducing weekly 
alcohol consumption, reducing heavy episodic drinking, and improving adherence to single 
day and weekly limits.26 Screening and brief intervention delivered electronically through 
computers, telephones, and mobile devices are also effective at reducing excessive alcohol 
consumption.27 The small percentage of patients who suffer from a severe alcohol use 
disorder can be referred for specialized treatment following brief intervention or treated in 
the primary care setting with medication-assisted treatment.19
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The overall prevalence of screening in this study (96%) was slightly higher than estimates 
from earlier studies based on provider surveys (85%–88%).14,21 The higher prevalence in 
this study could be because DocStyles asked providers to select from a list of specific 
screening methods, which could have facilitated better recall, rather than asking generally 
about whether they screened patients. The differences could also be because of differences 
in sampling methodologies and populations. More research is needed to determine whether 
the differences reflect actual increases in the prevalence of screening for alcohol misuse in 
the past decade.
Studies based on patient surveys found that 25%–78% of patients received alcohol screening 
in person or by form.28,29 In addition to differences in sampling methodologies, the lower 
estimates from patient surveys than provider surveys may be because of under-reporting 
among patients or over-reporting among providers. Specifically, patient surveys may be 
subject to greater recall bias because patients might only be screened at their first visit or 
during an annual checkup, whereas provider surveys may be subject to greater social 
desirability bias. It may also be a result of providers screening using a form and never 
communicating the results with their patients.
Although no study looked at predictors of using USPSTF-preferred screening tools, previous 
studies21,22 found that knowledge of guidelines and provider specialty were predictors of 
using a formal screening tool in general. Specifically, knowledge about NIAAA drinking 
guidelines predicted using a formal screening tool among doctors and nurse practitioners in 
a managed care organization,22 and internists were more likely to use formal screening tools 
than family physicians or OB/GYNs.21 The lower use of formal or USPSTF-preferred tools 
among OB/GYNs might be because OB/GYNs are interested in establishing whether or not 
their pregnant patient drinks any alcohol. However, USPSTF-preferred tools assess quantity 
and frequency of alcohol consumption, making them suitable tools for OB/GYNs to screen 
both pregnant and non-pregnant patients.13 Further research is warranted to determine 
whether provider specialty and asking screening questions via in-person interview are 
consistently associated with using formal screening tools and, in particular, formal tools 
capable of detecting the full spectrum of alcohol misuse.
Limitations
The study is subject to at least six limitations. First, DocStyles respondents may not be 
representative of providers within their specialty. Moreover, data were not weighted so the 
percentages reported for the total sample may not be nationally representative. For these 
reasons, the results might not be generalizable to all U.S. PCPs. Second, the survey relied on 
providers’ self-report, making it subject to social desirability and recall bias. Third, the 
question about choice of screening tools did not list all formal alcohol screening tools as 
options for the respondents. As such, the other screening method category could have 
included formal tools like the Michigan Alcohol Screening Test,30 the Alcohol-Related 
Problems Survey,31 or even multi-drug screening tools like the Alcohol, Smoking and 
Substance Involvement Screening Test.32 Because these tools are not USPSTF-preferred 
screening tools, this limitation has little impact on this study’s findings. Fourth, providers 
that reported using CAGE and asking patients about the number of drinks per occasion and 
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frequency of drinking could potentially detect patients who misuse alcohol, even though 
they did not use a USPSTF-preferred screening tool. However, this combination of tools was 
not included because it does not have a formal threshold for identifying patients who misuse 
alcohol and because the provider could have used each tool on separate occasions rather than 
in combination. Fifth, the list of screening tools in the survey did not include the USAUDIT 
and USAUDIT1–3, which are updated versions of the AUDIT and AUDIT-C.33,34 These 
updated tools could reduce potential misclassification from using the AUDIT-C35 by 
accounting for the larger standard drink size in the U.S. (14 g instead of 10 g of alcohol for 
international standard drinks),17 and lower NIAAA drinking limits among women and older 
men (www.niaaa.nih.gov/alcohol-health/overview-alcohol-consumption/moderate-binge-
drinking). Lastly, the cross-sectional nature of the survey made it impossible to determine 
causal relationships, only predictors of using a USPSTF-preferred screening tool. Despite 
these limitations, this is the first study assessing the prevalence of using USPSTF-preferred 
screening tools among providers, based on the updated 2013 USPSTF recommendations.
CONCLUSIONS
Although almost all providers in the study reported screening patients for alcohol misuse, a 
majority of these providers who screen do not use a validated tool that measures alcohol 
consumption and, therefore, may not be able to identify the large number of patients who 
drink too much, but are not dependent on alcohol. Because nondependent excessive drinkers 
outnumber dependent drinkers by more than eight to one,11 this represents a significant 
missed opportunity for prevention. Using suitable screening tools will allow providers to 
better identify patients with alcohol misuse behaviors so that they can conduct appropriate 
clinical interventions. In addition to clinical strategies, community-level prevention 
strategies, such as increasing alcohol taxes, limiting alcohol outlet density, and limiting days 
or hours of alcohol sales, are effective at reducing excessive alcohol consumption.36 
Applying both clinical and community-level strategies can reduce the burden from the many 
conditions associated with excessive alcohol consumption.
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Table 3
Selected Characteristics Associated With Using USPSTF-Preferred Screening Tools Among PCPs Who 
Screen, DocStyles 2016 (n=1,434)
Measures Prevalence (%) Unadjusted χ2 p-value APRa 95% CI
Overall 38
Provider demographics
 Age 0.681
  ≤40 years 39 ref
  41–50 years 39 1.09 0.93, 1.28
  >50 years 37 1.07 0.90, 1.26
 Gender 0.273
  Male 39 1.11 0.96, 1.29
  Female 37 ref
 Race/ethnicity 0.227
  White, non-Hispanic 38 1.34 0.86, 2.08
  Black, non-Hispanic 30 ref
  Asian, non-Hispanic 42 1.40 0.88, 2.22
  Hispanic 28 1.06 0.60, 1.87
  Other, non-Hispanic 40 1.43 0.87, 2.34
Practice characteristicsb
 Specialty <0.001
  Family practitioner 45 2.16 1.66, 2.81
  Internist 40 1.83 1.40, 2.39
  OB/GYN 20 ref
  Nurse practitioner 41 1.98 1.48, 2.66
 Size of practice 0.041
  ≤5 practitioners 36 ref
  >5 practitioners 41 1.13 0.99, 1.29
 Awareness of alcohol SBI as a preventive service recommended by the 
USPSTF
0.003
  Yes 40 1.22 1.02, 1.47
  No 30 ref
 How are screening questions administered? <0.001
  Form only 22 ref
  In-person interview only 36 1.56 1.17, 2.07
  Form and interview 59 2.52 1.88, 3.37
  Electronic/other 21 0.91 0.52, 1.60
Note: Boldface indicates statistical significance (p<0.05).
aAdjusted for all other covariates in the model.
Am J Prev Med. Author manuscript; available in PMC 2019 February 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Tan et al. Page 15
b
The following practice characteristics did not have significant bivariate associations (χ2 p-value>0.05) and were omitted from the multivariate 
model: main work setting, years in practice, number of patients per week, region, and financial situation of patients.
APR, adjusted prevalence ratio; PCP, primary care provider; ref, reference; SBI, screening and brief intervention; USPSTF, U.S. Preventive 
Services Task Force.
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